These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stimuli responsive systems constructed using cucurbit[n]uril-type molecular containers. Isaacs L Acc Chem Res; 2014 Jul; 47(7):2052-62. PubMed ID: 24785941 [TBL] [Abstract][Full Text] [Related]
3. Acyclic Cucurbit[n]uril-Type Containers as Receptors for Neuromuscular Blocking Agents: Structure-Binding Affinity Relationships. Shaya D; Isaacs L Croat Chem Acta; 2019 Jul; 92(2):163-171. PubMed ID: 32855560 [TBL] [Abstract][Full Text] [Related]
4. Acyclic cucurbit[n]uril congeners are high affinity hosts. Ma D; Zavalij PY; Isaacs L J Org Chem; 2010 Jul; 75(14):4786-95. PubMed ID: 20540586 [TBL] [Abstract][Full Text] [Related]
5. Cucurbit[n]uril formation proceeds by step-growth cyclo-oligomerization. Huang WH; Zavalij PY; Isaacs L J Am Chem Soc; 2008 Jul; 130(26):8446-54. PubMed ID: 18529059 [TBL] [Abstract][Full Text] [Related]
6. Diastereoselective formation of glycoluril dimers: isomerization mechanism and implications for cucurbit[n]uril synthesis. Chakraborty A; Wu A; Witt D; Lagona J; Fettinger JC; Isaacs L J Am Chem Soc; 2002 Jul; 124(28):8297-306. PubMed ID: 12105910 [TBL] [Abstract][Full Text] [Related]
7. Acyclic cucurbit[n]uril-type molecular containers: influence of glycoluril oligomer length on their function as solubilizing agents. Gilberg L; Zhang B; Zavalij PY; Sindelar V; Isaacs L Org Biomol Chem; 2015 Apr; 13(13):4041-50. PubMed ID: 25731639 [TBL] [Abstract][Full Text] [Related]
8. Acyclic congener of cucurbituril: synthesis and recognition properties. Burnett CA; Witt D; Fettinger JC; Isaacs L J Org Chem; 2003 Aug; 68(16):6184-91. PubMed ID: 12895048 [TBL] [Abstract][Full Text] [Related]
9. Uptake of Hydrocarbons in Aqueous Solution by Encapsulation in Acyclic Cucurbit[n]uril-Type Molecular Containers. Lu X; Isaacs L Angew Chem Int Ed Engl; 2016 Jul; 55(28):8076-80. PubMed ID: 27169688 [TBL] [Abstract][Full Text] [Related]
10. Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors. Hettiarachchi G; Samanta SK; Falcinelli S; Zhang B; Moncelet D; Isaacs L; Briken V Mol Pharm; 2016 Mar; 13(3):809-18. PubMed ID: 26756920 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of a Disulfonated Derivative of Cucurbit[7]uril and Investigations of its Ability to Solubilize Insoluble Drugs. Robinson EL; Zavalij PY; Isaacs L Supramol Chem; 2015 May; 27(5-6):288-297. PubMed ID: 25937787 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel interaction with cucurbit [7]uril and acyclic Cucurbit[4]uril nanocontainers: A computational approach. Ahmadian N; Amininasab M; Mehrnejad F J Mol Graph Model; 2019 Jul; 90():210-218. PubMed ID: 31103913 [TBL] [Abstract][Full Text] [Related]
13. Cucurbit[n]urils: from mechanism to structure and function. Isaacs L Chem Commun (Camb); 2009 Feb; (6):619-29. PubMed ID: 19322405 [TBL] [Abstract][Full Text] [Related]
14. Molecular Insight into the Interaction between Camptothecin and Acyclic Cucurbit[4]urils as Efficient Nanocontainers in Comparison with Cucurbit[7]uril: Molecular Docking and Molecular Dynamics Simulation. Ahmadian N; Mehrnejad F; Amininasab M J Chem Inf Model; 2020 Mar; 60(3):1791-1803. PubMed ID: 31944098 [TBL] [Abstract][Full Text] [Related]
15. Acyclic cucurbit[n]uril-type molecular containers: influence of aromatic walls on their function as solubilizing excipients for insoluble drugs. Zhang B; Isaacs L J Med Chem; 2014 Nov; 57(22):9554-63. PubMed ID: 25369565 [TBL] [Abstract][Full Text] [Related]